Douglas A. Melton
Douglas A. Melton | |
---|---|
Born | September 26, 1953 |
Alma mater | University of Illinois, B.S. Biology
Cambridge University, B.A. History and Philosophy of Science Cambridge University, Ph.D. Molecular Biology |
Awards | George Ledlie Prize, Richard Lounsbery Award, Eliot P. Joslin Medal |
Scientific career | |
Fields | Stem cell biology
Developmental biology |
Institutions | Harvard Stem Cell Institute Harvard University Faculty of Arts and Sciences, Department of Stem Cell and Regenerative Biology and Department of Molecular and Cellular Biology Howard Hughes Medical Institute National Academy of Science |
Douglas A. Melton is the co-director of the Harvard Stem Cell Institute, an investigator of the Howard Hughes Medical Institute, the Thomas Dudley Cabot Professor in the Natural Sciences of the [[Harvard Faculty of Arts and Sciences|Harvard University Faculty of Arts and Sciences, chairperson of the Harvard University Department of Stem Cell and Regenerative Biology, a faculty member of the Department of Molecular and Cellular Biology, a member of the National Academy of Science, a founding member of the International Society for Stem Cell Research, and is on the Science Advisory Board of the Genetics Policy Institute.
His research into stem cell therapies is motivated in part by his children's affliction with Type 1 diabetes. He is known for pioneering work in developmental biology of the pancreas.
In 2001 when President George W. Bush cut federal funding of embryonic stem cell research, Melton used private donations to create 17 published[1] stem cell lines and distribute them without charge to researchers around the world.
In 2007, Melton was listed among Time Magazine's 100 Most Influential People in The World.
Sources
- Douglas Melton - the Time 100
References
- ^ Cowan, C.A. et al. "Derivation of Embryonic Stem-Cell Lines from Human Blastocysts", New England Journal of Medicine